vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Sachem Capital Corp. (SACH). Click either name above to swap in a different company.
Sachem Capital Corp. is the larger business by last-quarter revenue ($12.0M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). Sachem Capital Corp. runs the higher net margin — 8.3% vs -234.3%, a 242.6% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -18.8%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -13.4%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Sachem Capital Corp.SACHEarnings & Financial Report
Sachem Head Capital Management is an American value-oriented investment management firm based in New York City, managed by Scott Ferguson.
FHTX vs SACH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $12.0M |
| Net Profit | $-21.7M | $997.0K |
| Gross Margin | — | — |
| Operating Margin | -258.2% | -3.1% |
| Net Margin | -234.3% | 8.3% |
| Revenue YoY | 223.8% | -18.8% |
| Net Profit YoY | -11.1% | 119.7% |
| EPS (diluted) | $-0.35 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | — | ||
| Q3 25 | $8.2M | $12.0M | ||
| Q2 25 | $7.6M | $10.8M | ||
| Q1 25 | $6.0M | $11.4M | ||
| Q4 24 | $2.9M | $10.8M | ||
| Q3 24 | $7.8M | $14.8M | ||
| Q2 24 | $6.9M | $15.1M | ||
| Q1 24 | $5.0M | $16.8M |
| Q4 25 | $-21.7M | — | ||
| Q3 25 | $-15.8M | $997.0K | ||
| Q2 25 | $-17.9M | $1.9M | ||
| Q1 25 | $-18.8M | $904.0K | ||
| Q4 24 | $-19.5M | $-36.1M | ||
| Q3 24 | $-19.1M | $-5.1M | ||
| Q2 24 | $-23.0M | $-3.1M | ||
| Q1 24 | $-25.0M | $4.7M |
| Q4 25 | -258.2% | — | ||
| Q3 25 | -226.9% | -3.1% | ||
| Q2 25 | -279.2% | 9.9% | ||
| Q1 25 | -385.0% | 9.0% | ||
| Q4 24 | -840.5% | -131.1% | ||
| Q3 24 | -305.5% | -32.6% | ||
| Q2 24 | -386.6% | -20.6% | ||
| Q1 24 | -558.3% | 25.4% |
| Q4 25 | -234.3% | — | ||
| Q3 25 | -194.4% | 8.3% | ||
| Q2 25 | -237.3% | 17.5% | ||
| Q1 25 | -316.4% | 7.9% | ||
| Q4 24 | -682.9% | -335.6% | ||
| Q3 24 | -244.9% | -34.2% | ||
| Q2 24 | -333.6% | -20.2% | ||
| Q1 24 | -495.4% | 27.8% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.25 | $0.00 | ||
| Q2 25 | $-0.28 | $0.02 | ||
| Q1 25 | $-0.30 | $0.00 | ||
| Q4 24 | $-0.23 | $-0.79 | ||
| Q3 24 | $-0.31 | $-0.13 | ||
| Q2 24 | $-0.45 | $-0.09 | ||
| Q1 24 | $-0.59 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $12.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $175.6M |
| Total Assets | $198.1M | $484.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | $12.6M | ||
| Q2 25 | $72.6M | $23.5M | ||
| Q1 25 | $61.0M | $25.8M | ||
| Q4 24 | $55.5M | $19.6M | ||
| Q3 24 | $57.7M | $7.4M | ||
| Q2 24 | $138.9M | $12.4M | ||
| Q1 24 | $79.3M | $56.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $230.2M | ||
| Q4 24 | — | $230.2M | ||
| Q3 24 | — | $264.7M | ||
| Q2 24 | — | $264.7M | ||
| Q1 24 | — | $288.4M |
| Q4 25 | $-108.5M | — | ||
| Q3 25 | $-89.7M | $175.6M | ||
| Q2 25 | $-76.7M | $177.9M | ||
| Q1 25 | $-61.7M | $179.3M | ||
| Q4 24 | $-45.5M | $181.7M | ||
| Q3 24 | $-28.3M | $220.6M | ||
| Q2 24 | $-14.3M | $230.2M | ||
| Q1 24 | $-97.5M | $237.4M |
| Q4 25 | $198.1M | — | ||
| Q3 25 | $205.0M | $484.4M | ||
| Q2 25 | $226.2M | $501.8M | ||
| Q1 25 | $258.7M | $491.4M | ||
| Q4 24 | $284.0M | $492.0M | ||
| Q3 24 | $308.4M | $555.5M | ||
| Q2 24 | $328.6M | $586.3M | ||
| Q1 24 | $255.0M | $626.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 1.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $4.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 4.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | — | ||
| Q3 25 | $-18.9M | $4.9M | ||
| Q2 25 | $-21.0M | $501.0K | ||
| Q1 25 | $-24.0M | $191.0K | ||
| Q4 24 | $-24.5M | $12.9M | ||
| Q3 24 | $-21.0M | $2.3M | ||
| Q2 24 | $-25.5M | $7.0M | ||
| Q1 24 | $-29.3M | $4.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.95× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
